pyrroles has been researched along with Systemic Inflammatory Response Syndrome in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ak, K; Arsan, S; Gulsoy, O; Isbir, S; Sahin, Y; Tetik, S; Yardimci, T | 1 |
Kruger, P; Phillips, LK; Prins, J; Robinson, K; Venkatesh, B | 1 |
Amemiya, K; Blackwood, E; Cain, G; Dambach, D; Diaz, D; Dybdal, N; Erickson, RI; Fairbrother, WJ; Flygare, JA; Lewin-Koh, SC; Mamounas, M; Steigerwalt, R; Tarrant, J; West, K; Wong, H | 1 |
Hanson, SY; Johnson, AC; Zager, RA | 1 |
Ahumada, M; Arcas, R; Arribas, JM; Gomez-Plana, J; Marín, F; Martínez, P; Oliver, C; Pascual, DA; Tornel, PL; Valdes, M | 1 |
Agrò, F; Candura, D; Carassiti, M; Chello, M; Covino, E; Di Sciascio, G; Mastrobuoni, S; Patti, G | 1 |
Aznaouridis, K; Dagre, A; Masoura, C; Pitsavos, C; Skoumas, J; Stefanadi, E; Stefanadis, C; Vasiliadou, C; Vlachopoulos, C | 1 |
4 trial(s) available for pyrroles and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting.
Topics: Aged; Atorvastatin; Coronary Artery Bypass; Cytokines; Female; Fibrinolysis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Postoperative Complications; Pyrroles; Systemic Inflammatory Response Syndrome; Tissue Plasminogen Activator | 2011 |
Preoperative statin therapy and troponin T predict early complications of coronary artery surgery.
Topics: Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Comorbidity; Coronary Artery Bypass; Creatine Kinase, MB Form; Female; Heptanoic Acids; Hospital Mortality; Hospitals, University; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Interleukin-6; Lipids; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pravastatin; Premedication; Preoperative Care; Prospective Studies; Pyrroles; Risk Assessment; Simvastatin; Systemic Inflammatory Response Syndrome; Troponin T | 2006 |
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery.
Topics: Aged; Analysis of Variance; Atorvastatin; Coronary Artery Bypass; Cytokines; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neutrophil Activation; Postoperative Complications; Pyrroles; Systemic Inflammatory Response Syndrome | 2006 |
Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.
Topics: Adult; Atorvastatin; Brachial Artery; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Oxidative Stress; Pyrroles; Salmonella typhi; Salmonella Vaccines; Systemic Inflammatory Response Syndrome; Vascular Diseases; Vasodilation | 2007 |
3 other study(ies) available for pyrroles and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Effect of statin therapy on plasma adiponectin concentrations in patients with the sepsis syndrome: a preliminary investigation.
Topics: Adiponectin; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Systemic Inflammatory Response Syndrome | 2011 |
Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-α pharmacology.
Topics: Animals; Antineoplastic Agents; Chemokines; Cyclohexanes; Dogs; Female; Inhibitor of Apoptosis Proteins; Liver; Lung; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Species Specificity; Systemic Inflammatory Response Syndrome; Toxicity Tests; Tumor Necrosis Factor-alpha | 2013 |
Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter.
Topics: Animals; Atorvastatin; Blood Proteins; CD36 Antigens; Cholesterol; Escherichia coli; Female; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Cortex; Kidney Tubules, Proximal; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; Pyrroles; Receptors, Immunologic; Receptors, LDL; Receptors, Lipoprotein; Receptors, Scavenger; RNA, Messenger; Scavenger Receptors, Class B; Systemic Inflammatory Response Syndrome | 2003 |